America In-Vitro Diagnostics Market is predicted to reach USD 49.62 Billion by 2030

According to the study by Next Move Strategy Consulting, the America In-Vitro Diagnostics Market size is predicted to reach USD 49.62 billion, with a CAGR of 3.6% by 2030.

Request a FREE Sample: https://www.nextmsc.com/america-in-vitro-diagnostics-market/request-sample

The rapidly growing prevalence of chronic and infectious diseases such as cancer, heart diseases, diabetes, and other various infections, is boosting the demand for diagnostic tests in the in-vitro diagnostics market in America.

The aging population, driven by its increasing prevalence of age-related diseases and conditions worldwide, serves as a primary factor for the America in-vitro diagnostics market growth.

The prevalence of chronic diseases in the U.S. is the major factor driving the growth of the America in-vitro diagnostics market trends in the region.

Several market players operating in the America in-vitro diagnostics industry include Roche Holding AG, Abbott Laboratories, Thermo Fisher Scientific Inc, Danaher Corporation, Becton, Dickinson and Company, Siemens Healthineers AG, bioMérieux SA, Sysmex Corporation, QIAGEN N.V., and Bio-Rad Laboratories, Inc., and others.